Skip to main content
. Author manuscript; available in PMC: 2012 Oct 1.
Published in final edited form as: Curr Opin Pharmacol. 2011 Aug 9;11(5):464–469. doi: 10.1016/j.coph.2011.07.004

FIG. 2.

FIG. 2

Observed individual concentrations of CMS (Panels A and B) and formed colistin (Panels C and D) in plasma of critically-ill patients after the administration of the first (Panels A and C; fourteen patients) and fourth (Panels B and D; 12 patients) dose of CMS. Reproduced from Plachouras et al.[17] with permission.